EQIS Capital Management Boosts Stake in Sinovac Biotech Ltd.

EQIS Capital Management Boosts Stake in Sinovac Biotech Ltd.


EQIS Capital Management boosted its position in Sinovac Biotech Ltd. by 6,472.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission . The firm owned 240,674 shares of the biopharmaceutical company's stock after buying an additional 237,012 shares during the period.



from Biotech News